Strengthening Australian Infectious Disease Clinical Research with a focus on vulnerable populations

  • Funded by National Health and Medical Research Council (NHMRC)
  • Total publications:0 publications

Grant number: GA271310

Grant search

Key facts

  • Disease

    COVID-19
  • Start & end year

    2023
    2027
  • Known Financial Commitments (USD)

    $1,520,363.31
  • Funder

    National Health and Medical Research Council (NHMRC)
  • Principal Investigator

    N/A

  • Research Location

    Australia
  • Lead Research Institution

    University of New South Wales
  • Research Priority Alignment

    N/A
  • Research Category

    14

  • Research Subcategory

    N/A

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Drug usersVulnerable populations unspecified

  • Occupations of Interest

    Unspecified

Abstract

This research aims to study treatments for infectious diseases that affect particularly vulnerable communities including people who inject drugs and people living with HIV. It focuses on finding solutions that will aid progress towards elimination of hepatitis B and C, and towards managing the pandemics of HIV and COVID-19, through the establishment of high quality international collaborative clinical research.